Boutin M - Search Results

1

Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment.

Mhanni A, Boutin M, Stockl F, Johnston J, Barnes J, Duerksen D, Zimmer L, Auray-Blais C, Rockman-Greenberg C. Mhanni A, et al. Among authors: boutin m. Diagnostics (Basel). 2020 Jan 26;10(2):69. doi: 10.3390/diagnostics10020069. Diagnostics (Basel). 2020. PMID: 31991859 Free PMC article.

2

Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.

Auray-Blais C, Boutin M, Gagnon R, Dupont FO, Lavoie P, Clarke JT. Auray-Blais C, et al. Among authors: boutin m. Anal Chem. 2012 Mar 20;84(6):2745-53. doi: 10.1021/ac203433e. Epub 2012 Feb 28. Anal Chem. 2012. PMID: 22309310

3

Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic study.

Auray-Blais C, Boutin M. Auray-Blais C, et al. Among authors: boutin m. Curr Med Chem. 2012;19(19):3241-52. doi: 10.2174/092986712800784739. Curr Med Chem. 2012. PMID: 22612706

4

LC-MS/MS analysis of plasma lyso-Gb3 in Fabry disease.

Boutin M, Gagnon R, Lavoie P, Auray-Blais C. Boutin M, et al. Clin Chim Acta. 2012 Dec 24;414:273-80. doi: 10.1016/j.cca.2012.09.026. Epub 2012 Oct 2. Clin Chim Acta. 2012. PMID: 23041216

5

A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers.

Dupont FO, Gagnon R, Boutin M, Auray-Blais C. Dupont FO, et al. Among authors: boutin m. Curr Med Chem. 2013;20(2):280-8. doi: 10.2174/092986713804806685. Curr Med Chem. 2013. PMID: 23092136

6

Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.

Lavoie P, Boutin M, Auray-Blais C. Lavoie P, et al. Among authors: boutin m. Anal Chem. 2013 Feb 5;85(3):1743-52. doi: 10.1021/ac303033v. Epub 2013 Jan 7. Anal Chem. 2013. PMID: 23248976 Clinical Trial.

7

A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients.

Manwaring V, Boutin M, Auray-Blais C. Manwaring V, et al. Among authors: boutin m. Anal Chem. 2013 Oct 1;85(19):9039-48. doi: 10.1021/ac401542k. Epub 2013 Sep 11. Anal Chem. 2013. PMID: 23968398

8

Multiplex tandem mass spectrometry analysis of novel plasma lyso-Gb₃-related analogues in Fabry disease.

Boutin M, Auray-Blais C. Boutin M, et al. Anal Chem. 2014 Apr 1;86(7):3476-83. doi: 10.1021/ac404000d. Epub 2014 Mar 17. Anal Chem. 2014. PMID: 24634980

9

Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.

Auray-Blais C, Blais CM, Ramaswami U, Boutin M, Germain DP, Dyack S, Bodamer O, Pintos-Morell G, Clarke JT, Bichet DG, Warnock DG, Echevarria L, West ML, Lavoie P. Auray-Blais C, et al. Among authors: boutin m. Clin Chim Acta. 2015 Jan 1;438:195-204. doi: 10.1016/j.cca.2014.08.002. Epub 2014 Aug 19. Clin Chim Acta. 2015. PMID: 25149322 Clinical Trial.

10

Metabolomic discovery of novel urinary galabiosylceramide analogs as Fabry disease biomarkers.

Boutin M, Auray-Blais C. Boutin M, et al. J Am Soc Mass Spectrom. 2015 Mar;26(3):499-510. doi: 10.1007/s13361-014-1060-3. Epub 2015 Jan 13. J Am Soc Mass Spectrom. 2015. PMID: 25582508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page